230 related articles for article (PubMed ID: 31000859)
1. Gastrointestinal and pancreatic neuroendocrine tumours and carcinomas; a review of rare tumour type.
Siddiqa A; Adel H; Khan SA; Huda F; Sattar A
J Pak Med Assoc; 2019 Apr; 69(4):533-540. PubMed ID: 31000859
[TBL] [Abstract][Full Text] [Related]
2. [CT and MRI findings of primary hepatic neuroendocrine neoplasm].
Li JK; Wang M; Yuan J; Song ZG
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):600-606. PubMed ID: 28835083
[No Abstract] [Full Text] [Related]
3. [Morphological imaging of gastroenteropancreatic neuroendocrine tumours].
Camera L; Bresciani M; Soscia E; Percopo V; Mainenti PP; Salvatore M
Minerva Endocrinol; 2001 Sep; 26(3):123-8. PubMed ID: 11753234
[TBL] [Abstract][Full Text] [Related]
4. Positron-emission tomography as a radiological technique in neuroendocrine gastrointestinal tumors.
Eriksson B; Lilja A; Ahlström H; Bjurling P; Bergström M; Lindner KJ; Långström B; Oberg K
Ann N Y Acad Sci; 1994 Sep; 733():446-52. PubMed ID: 7978893
[No Abstract] [Full Text] [Related]
5. Neuroendocrine tumours: clinical presentation and management of localized disease.
Kulke MH
Cancer Treat Rev; 2003 Oct; 29(5):363-70. PubMed ID: 12972355
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced ultrasonography in evaluating hepatic metastases from neuroendocrine tumours.
Massironi S; Conte D; Sciola V; Pirola L; Paggi S; Fraquelli M; Ciafardini C; Spampatti MP; Peracchi M
Dig Liver Dis; 2010 Sep; 42(9):635-41. PubMed ID: 20172770
[TBL] [Abstract][Full Text] [Related]
7. CT/MRI of neuroendocrine tumours.
Reznek RH
Cancer Imaging; 2006 Oct; 6(Spec No A):S163-77. PubMed ID: 17114072
[TBL] [Abstract][Full Text] [Related]
8. Advances in the cytologic diagnosis of gastroenteropancreatic neuroendocrine neoplasms.
Sigel CS
Cancer Cytopathol; 2018 Dec; 126(12):980-991. PubMed ID: 30485690
[TBL] [Abstract][Full Text] [Related]
9. [Gastroenteropancreatic neuroendocrine tumours (carcinoid tumours): definition, clinical aspects, diagnosis and therapy].
Bodelier AG; Haak HR
Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1868-72. PubMed ID: 16970007
[TBL] [Abstract][Full Text] [Related]
10. Importance of vesicle proteins in the diagnosis and treatment of neuroendocrine tumors.
Nilsson O; Jakobsen AM; Kölby L; Bernhardt P; Forssell-Aronsson E; Ahlman H
Ann N Y Acad Sci; 2004 Apr; 1014():280-3. PubMed ID: 15153446
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours.
Gibril F; Jensen RT
Dig Liver Dis; 2004 Feb; 36 Suppl 1():S106-20. PubMed ID: 15077919
[TBL] [Abstract][Full Text] [Related]
12. Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study.
Kann PH; Balakina E; Ivan D; Bartsch DK; Meyer S; Klose KJ; Behr T; Langer P
Endocr Relat Cancer; 2006 Dec; 13(4):1195-202. PubMed ID: 17158764
[TBL] [Abstract][Full Text] [Related]
13. The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond.
Sorbye H; Baudin E; Perren A
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):683-698. PubMed ID: 30098724
[TBL] [Abstract][Full Text] [Related]
14. Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours.
Oberg K; Eriksson B
Best Pract Res Clin Endocrinol Metab; 2005 Jun; 19(2):265-76. PubMed ID: 15763700
[TBL] [Abstract][Full Text] [Related]
15. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U
Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861
[TBL] [Abstract][Full Text] [Related]
16. Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options.
Arnold R
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):491-505. PubMed ID: 16183523
[TBL] [Abstract][Full Text] [Related]
17. Prediction of clinical outcome in treated neuroendocrine tumours of carcinoid type using functional volumes on 111In-pentetreotide SPECT imaging.
Gopinath G; Ahmed A; Buscombe JR; Dickson JC; Caplin ME; Hilson AJ
Nucl Med Commun; 2004 Mar; 25(3):253-7. PubMed ID: 15094443
[TBL] [Abstract][Full Text] [Related]
18. Standard imaging techniques for neuroendocrine tumors.
Bushnell DL; Baum RP
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):153-62, ix. PubMed ID: 21349416
[TBL] [Abstract][Full Text] [Related]
19. Gastroenteropancreatic neuroendocrine neoplasms: selected pathology review and molecular updates.
Chai SM; Brown IS; Kumarasinghe MP
Histopathology; 2018 Jan; 72(1):153-167. PubMed ID: 29239038
[TBL] [Abstract][Full Text] [Related]
20. Molecular imaging of gastroenteropancreatic neuroendocrine tumors.
Miederer M; Weber MM; Fottner C
Gastroenterol Clin North Am; 2010 Dec; 39(4):923-35. PubMed ID: 21093764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
